Abiopharma

NASDAQ traded attribute type Security_Name was changed. Previous value: Oncocyte Corporation - Common Stock. New value: Oncocyte Corporation - Common Stock.

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

New Form 3 - Serina Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001708599-25-000060 Size: 3 KB

New Form 4 - Kodiak Sciences Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017624 Size: 9 KB

New Form 4 - Whitehawk Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017620 Size: 6 KB

The Latest on Gladiator 3: What We Know So Far

New Form SCHEDULE 13D/A - Butterfly Network, Inc. Filed: 2025-06-17 AccNo: 0000905148-25-002180 Size: 10 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017613 Size: 7 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017615 Size: 7 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017614 Size: 7 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017616 Size: 8 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017611 Size: 7 KB

New Form 4 - KALA BIO, Inc. Filed: 2025-06-17 AccNo: 0001415889-25-017612 Size: 7 KB

New Form 4 - PUMA BIOTECHNOLOGY, INC. Filed: 2025-06-17 AccNo: 0001437749-25-020721 Size: 6 KB

New Form 4 - PUMA BIOTECHNOLOGY, INC. Filed: 2025-06-17 AccNo: 0001437749-25-020719 Size: 5 KB